U.S. Emerging Psoriasis Therapeutics Market

 

Regular Price: USD 2,450

Special Price USD 1,715

30% OFF

* Required Fields

Regular Price: USD 2,450

Special Price USD 1,715

PAY BY INVOICE

Be the first to review this product

This report evaluates the current state of the U.S. emerging psoriasis therapeutics market and forecasts future revenues, revenue growth and product pricing for the period 1997 to 2007, with 2000 as the base year. Key issues and trends are discussed relative to the future of the market. The report also identifies the key challenges facing the industry and offers strategic recommendations to business departments to overcome these obstacles. Market drivers and restraints are evaluated for the total market as well as the two segments, emerging monoclonal antibodies and other emerging products, and their impact on the revenue forecast discussed in detail. The report also discusses technology trends likely to have an impact on the future market for psoriasis.

Table of Contents

U.S. Emerging Psoriasis Therapeutics Market, Executive SummaryMarket OverviewIntroductionCompetitive AnalysisTechnologiesMajor Research FindingsOpportunitiesMarket Segment Analysis and Revenue ForecastStrategic ConclusionsStrategic RecommendationsU.S. Emerging Psoriasis Therapeutics Market, Total MarketOverviewIntroductionTreatment Overview-Existing TherapiesTreatment Overview-Emerging TherapiesChallengesMarket Engineering AnalysisMarket DriversMarket RestraintsForecasts and TrendsDemand AnalysisEnd User TrendsRevenue ForecastsPricing TrendsMarket and Technology TrendsCompetitive AnalysisCompetitive StructureCompetitive AnalysisStrategic RecommendationsImpact of Challenges Drivers and RestraintsStrategic Recommendations-Challenge 1Strategic Recommendations-Challenge 2Strategic Recommendations-Challenge 3Strategic Recommendations-Challenge 4Strategic Recommendations-Challenge 5 Strategic Recommendations-Challenge 6Strategic Recommendations-Challenge 7Frost & Sullivan Market Engineering AwardsStrategic Alliance Leadership : Genentech Inc.Technology Innovation : ISIS PharmaceuticalsTechnology Leadership : Biogen IncWebsite Leadership : Protein Design Labs Inc.U.S. Emerging Psoriasis Therapeutics Market, Monoclonal AntibodiesOverviewIntroductionMarket Engineering AnalysisMarket DriversMarket RestraintsU.S. Emerging Monoclonal Antibody Psoriasis Market : Forecasts and TrendsRevenue ForecastsPricing TrendsU.S. Emerging Monoclonal Antibody Psoriasis Market : Competitive AnalysisCompetitive StructureProduct AnalysisU.S. Emerging Psoriasis Therapeutics Market, Other Emerging ProductsOverviewIntroductionMarket Engineering AnalysisMarket DriversMarket RestraintsOther Emerging Products in U.S. Psoriasis Market : Forecasts and TrendsRevenue ForecastsPricing TrendsCompetitive AnalysisCompetitive StructureProduct Analysis




Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.